Cargando…

Exploring Antibiotic-Potentiating Effects of Tobramycin–Deferiprone Conjugates in Pseudomonas aeruginosa

Metal ions, including Fe(3+), affect the target site binding of some antibiotics and control the porin- and siderophore-mediated uptake of antibiotics. Amphiphilic tobramycins are an emerging class of antibiotic potentiators capable of synergizing with multiple classes of antibiotics against Gram-ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gandhi, Karan, Dhiman, Shiv, Arora, Rajat, Ramirez, Danzel Marie, Ramirez, Danyel, Arthur, Gilbert, Schweizer, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451322/ https://www.ncbi.nlm.nih.gov/pubmed/37627681 http://dx.doi.org/10.3390/antibiotics12081261

Ejemplares similares

Trimeric Tobramycin/Nebramine Synergizes β-Lactam Antibiotics against Pseudomonas aeruginosa
por: Dhiman, Shiv, et al.
Publicado: (2023)

Guanidinylated Polymyxins as Outer Membrane Permeabilizers Capable of Potentiating Rifampicin, Erythromycin, Ceftazidime and Aztreonam against Gram-Negative Bacteria
por: Ramirez, Danzel Marie, et al.
Publicado: (2022)

Tobramycin-Linked Efflux Pump Inhibitor Conjugates Synergize Fluoroquinolones, Rifampicin and Fosfomycin against Multidrug-Resistant Pseudomonas aeruginosa
por: Yang, Xuan, et al.
Publicado: (2018)

Salmonella Typhimurium and Pseudomonas aeruginosa Respond Differently to the Fe Chelator Deferiprone and to Some Novel Deferiprone Derivatives
por: Ammendola, Serena, et al.
Publicado: (2021)

Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms
por: Armijo, Leisha M., et al.
Publicado: (2020)

RpoN Promotes Pseudomonas aeruginosa Survival in the Presence of Tobramycin
por: Viducic, Darija, et al.
Publicado: (2017)

Staphylococcus aureus interaction with Pseudomonas aeruginosa biofilm enhances tobramycin resistance
por: Beaudoin, T., et al.
Publicado: (2017)

Itaconic Acid Increases the Efficacy of Tobramycin against Pseudomonas aeruginosa Biofilms
por: Ho, Duy-Khiet, et al.
Publicado: (2020)

Gene Expression Profiling of Pseudomonas aeruginosa Upon Exposure to Colistin and Tobramycin
por: Cianciulli Sesso, Anastasia, et al.
Publicado: (2021)

Eradication of Pseudomonas aeruginosa in cystic fibrosis patients with inhalation of dry powder tobramycin
por: Akkerman-Nijland, Anne M., et al.
Publicado: (2020)

Combined Treatment of 6-Gingerol Analog and Tobramycin for Inhibiting Pseudomonas aeruginosa Infections
por: Ham, So-Young, et al.
Publicado: (2021)

Anti-bacterial mechanism of baicalin-tobramycin combination on carbapenem-resistant Pseudomonas aeruginosa
por: Jin, Li-Min, et al.
Publicado: (2023)

Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic Conjugate
por: Kajihara, Kimberly K., et al.
Publicado: (2021)

Combined effect of linolenic acid and tobramycin on Pseudomonas aeruginosa biofilm formation and quorum sensing
por: Chanda, Warren, et al.
Publicado: (2017)

Tobramycin reduces key virulence determinants in the proteome of Pseudomonas aeruginosa outer membrane vesicles
por: Koeppen, Katja, et al.
Publicado: (2019)

Tobramycin and Amikacin Delay Adhesion and Microcolony Formation in Pseudomonas aeruginosa Cystic Fibrosis Isolates
por: Olivares, Elodie, et al.
Publicado: (2017)

Tobramycin and bicarbonate synergise to kill planktonic Pseudomonas aeruginosa, but antagonise to promote biofilm survival
por: Kaushik, Karishma S, et al.
Publicado: (2016)

Involvement of Acquired Tobramycin Resistance in the Shift to the Viable but Non-Culturable State in Pseudomonas aeruginosa
por: Mangiaterra, Gianmarco, et al.
Publicado: (2023)

Effect of Bacteriophage Infection in Combination with Tobramycin on the Emergence of Resistance in Escherichia coli and Pseudomonas aeruginosa Biofilms
por: Coulter, Lindsey B., et al.
Publicado: (2014)

Role of Tobramycin in the Induction and Maintenance of Viable but Non-Culturable Pseudomonas aeruginosa in an In Vitro Biofilm Model
por: Mangiaterra, Gianmarco, et al.
Publicado: (2020)

Hydrogels Embedded With Melittin and Tobramycin Are Effective Against Pseudomonas aeruginosa Biofilms in an Animal Wound Model
por: Maiden, Michael M., et al.
Publicado: (2019)

The Xanthophyll Carotenoid Lutein Reduces the Invasive Potential of Pseudomonas aeruginosa and Increases Its Susceptibility to Tobramycin
por: Mahavy, Christian Emmanuel, et al.
Publicado: (2022)

Collateral Sensitivity to Fosfomycin of Tobramycin-Resistant Mutants of Pseudomonas aeruginosa Is Contingent on Bacterial Genomic Background
por: Genova, Roberta, et al.
Publicado: (2023)

A Cationic Porphyrin, ZnPor, Disassembles Pseudomonas aeruginosa Biofilm Matrix, Kills Cells Directly, and Enhances Antibiotic Activity of Tobramycin
por: Patel, Neha, et al.
Publicado: (2020)

Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection
por: Greenwood, James, et al.
Publicado: (2017)

Marine-Derived Quorum-Sensing Inhibitory Activities Enhance the Antibacterial Efficacy of Tobramycin against Pseudomonas aeruginosa
por: Busetti, Alessandro, et al.
Publicado: (2014)

Once daily aerosolised tobramycin in adult patients with cystic fibrosis in the management of Pseudomonas aeruginosa chronic infection
por: Mantero, Marco, et al.
Publicado: (2017)

A New PqsR Inverse Agonist Potentiates Tobramycin Efficacy to Eradicate Pseudomonas aeruginosa Biofilms
por: Schütz, Christian, et al.
Publicado: (2021)

Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa
por: Murphy, Ronan A., et al.
Publicado: (2022)

Designing New Hybrid Antibiotics: Proline-Rich Antimicrobial Peptides Conjugated to the Aminoglycoside Tobramycin
por: Gambato, Stefano, et al.
Publicado: (2023)

Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis
por: Lam, John, et al.
Publicado: (2013)

Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation
por: Price, Katherine E., et al.
Publicado: (2015)

Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
por: Panguluri, Srilekha, et al.
Publicado: (2017)

Ultrastructure imaging of Pseudomonas aeruginosa lawn biofilms and eradication of the tobramycin-resistant variants under in vitro electroceutical treatment
por: Lochab, Varun, et al.
Publicado: (2020)

Characterizations of the viability and gene expression of dispersal cells from Pseudomonas aeruginosa biofilms released by alginate lyase and tobramycin
por: Daboor, Said M., et al.
Publicado: (2021)

Is it Worth Adding Systemic Antibiotics to Inhalational Tobramycin Therapy to Treat Pseudomonas Infections in Cystic Fibrosis?
por: Karki, Kumar, et al.
Publicado: (2021)

Tobramycin at subinhibitory concentration inhibits the RhlI/R quorum sensing system in a Pseudomonas aeruginosa environmental isolate
por: Babić, Fedora, et al.
Publicado: (2010)

Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable Pseudomonas Aeruginosa Strains via Mechanism-Based Modelling
por: Rees, Vanessa E., et al.
Publicado: (2019)

Liposome-Encapsulated Tobramycin and IDR-1018 Peptide Mediated Biofilm Disruption and Enhanced Antimicrobial Activity against Pseudomonas aeruginosa
por: Alzahrani, Nouf M., et al.
Publicado: (2022)

A Pseudomonas aeruginosa PQS quorum-sensing system inhibitor with anti-staphylococcal activity sensitizes polymicrobial biofilms to tobramycin
por: Murray, Ewan J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i2ohfda5jo5mr2baubc8dlvda8